PHH Corp., Tutor Perini Corp., Blyth, Inc. and Symmetry Medical Inc.

CHICAGO--([ BUSINESS WIRE ])--Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): PHH Corp. (NYSE: [ PHH ])and Tutor Perini Corp. (NYSE: [ TPC ]). Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: Blyth, Inc. (NYSE: [ BTH ]) and Symmetry Medical Inc. (NYSE: [ SMA ]). To see the full Zacks #5 Rank List - Stocks to Sell Now visit: [ http://at.zacks.com/?id=92 ]

"Earnings estimate revisions are the most powerful force impacting stock prices."

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why PHH and TPC have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

PHH Corp. (NYSE: [ PHH ]) posted a third-quarter loss of 94 cents per share last month, wider than analysts' expectations of a loss of 1 cent. Net revenues slipped to $507 million from last year's $533 million. The Zacks Consensus Estimate for the current year is pegged at a profit of $1.28 per share that dropped from $2.32 in the last 60 days. Next year's forecast fell 77 cents to 98 cents per share in the same period.

Tutor Perini Corp. (NYSE: [ TPC ]) announced third-quarter earnings per share of 54 cents on Nov 5, which decreased 46% on a year-over-year basis. Earnings also missed the average forecast of 61 cents per share. Revenues fell 17% to $1.17 billion. The Zacks Consensus Estimate for the full year decreased 6 cents to $2.68 cents per share over the past 2 months.

Here is a synopsis of why BTH and SMA have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

Blyth, Inc. (NYSE: [ BTH ]) swung to a third-quarter loss of 5 cents per share on Dec 6, in contrast to the Zacks Consensus Estimate of a profit of 28 cents. Sales declined 12% to $221.6 million. In the year-ago quarter, Blyth had earned a profit of 80 cents per share. The average forecast for the current year slipped 10 cents to $2.25 per share in the last month as 1 analyst out of 2 reduced expectations.

Symmetry Medical Inc. (NYSE: [ SMA ]) now expects earnings per share of 63 to 68 cents, compared to its earlier guidance of 77 to 85 cents. Revenues are projected in the range of $355 to $365 million, lower than its prior view of $385 to $405 million. For 2009, the Zacks Consensus Estimate stands at 65 cents per share. On Nov 5, the company reported third-quarter earnings of 15 cents per share, which came in a penny shy of analysts' expectations.

Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report; "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions" is available to provide this insightful background. Download a free copy now to prosper in the years to come at [ http://at.zacks.com/?id=93 ]

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank Stocks have generated an average annual return of +27%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (-0.9% versus +9%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

Visit [ http://www.zacks.com/performance ] for information about the performance numbers displayed in this press release.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting [ http://at.zacks.com/?id=94 ]

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at [ http://at.zacks.com/?id=95 ]

Join us on Facebook: [ http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts ]

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

N@N

PHH Corp., Tutor Perini Corp., Blyth, Inc. and Symmetry Medical Inc.